Korea Investment CORP Boosts Stock Position in The Cooper Companies, Inc. (NASDAQ:COO)

Korea Investment CORP lifted its position in The Cooper Companies, Inc. (NASDAQ:COO) by 50.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 89,915 shares of the medical device company’s stock after purchasing an additional 30,100 shares during the quarter. Korea Investment CORP’s holdings in Cooper Companies were worth $8,266,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of COO. State Street Corp lifted its holdings in shares of Cooper Companies by 1.2% in the 3rd quarter. State Street Corp now owns 8,590,689 shares of the medical device company’s stock valued at $947,897,000 after buying an additional 104,521 shares during the period. JPMorgan Chase & Co. lifted its holdings in Cooper Companies by 13.2% in the third quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company’s stock valued at $543,979,000 after acquiring an additional 573,908 shares during the period. Geode Capital Management LLC boosted its position in Cooper Companies by 1.0% in the 3rd quarter. Geode Capital Management LLC now owns 4,796,556 shares of the medical device company’s stock worth $527,476,000 after purchasing an additional 48,559 shares in the last quarter. Victory Capital Management Inc. grew its stake in shares of Cooper Companies by 14.6% during the 4th quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company’s stock worth $415,985,000 after purchasing an additional 574,899 shares during the period. Finally, Swedbank AB increased its holdings in shares of Cooper Companies by 14.0% during the 4th quarter. Swedbank AB now owns 1,629,602 shares of the medical device company’s stock valued at $149,809,000 after purchasing an additional 200,000 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Stock Up 0.7 %

NASDAQ COO opened at $84.35 on Tuesday. The Cooper Companies, Inc. has a one year low of $77.05 and a one year high of $112.38. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The business has a fifty day moving average price of $89.15 and a 200 day moving average price of $97.03. The company has a market cap of $16.87 billion, a P/E ratio of 43.26, a P/E/G ratio of 2.25 and a beta of 1.02.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, hitting the consensus estimate of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The firm had revenue of $964.70 million for the quarter, compared to the consensus estimate of $981.25 million. Research analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research firms recently commented on COO. Citigroup dropped their price target on shares of Cooper Companies from $115.00 to $110.00 and set a “buy” rating on the stock in a research report on Friday, March 7th. Robert W. Baird cut their price target on Cooper Companies from $117.00 to $107.00 and set an “outperform” rating for the company in a research note on Friday, March 7th. StockNews.com cut Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday, December 11th. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a report on Friday, March 7th. Finally, BNP Paribas raised Cooper Companies to a “hold” rating in a research note on Thursday, March 13th. Four equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $110.25.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.